Showing results (11-20 of 27,912) with videos related to
Sort By:
Pageof 2,792
Nature|April 12, 1984
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidatesJ B Kaper, H Lockman, M M Baldini, et al.Developments in Biological Standardization|January 1, 1995
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effectsS J Cryz, J Kaper, C Tacket, et al.Infection and Immunity|January 1, 1996
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgRD W Acheson, M M Levine, J B Kaper, et al.The Journal of the Acoustical Society of America|April 29, 2006
Mechanism and calculation of the niche effect in airborne sound transmissionRoman VinokurVaccine|December 1, 1990
Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adultsS J Cryz, M M Levine, J B Kaper, et al.FEMS Microbiology Letters|July 15, 1993
Construction of genetically marked Vibrio cholerae O1 vaccine strainsJ M Ketley, J Michalski, J Galen, et al.The Journal of Infectious Diseases|June 1, 1990
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogenB Baudry, S J Savarino, P Vial, et al.Infection and Immunity|September 11, 1992
Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adultsS J Cryz, M M Levine, G Losonsky, et al.The Southeast Asian Journal of Tropical Medicine and Public Health|September 1, 1988
The current status of cholera vaccine development and experience with cholera vaccine trials in volunteersM M Levine, J B Kaper, D Herrington, et al.Infection and Immunity|May 1, 1990
Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103J M Ketley, J B Kaper, D A Herrington, et al.Pageof 2,792